Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Targeting the tumor mutanome for personalized vaccination therapy.

Kreiter S, Castle JC, Türeci O, Sahin U.

Oncoimmunology. 2012 Aug 1;1(5):768-769.

2.

Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines.

Türeci Ö, Vormehr M, Diken M, Kreiter S, Huber C, Sahin U.

Clin Cancer Res. 2016 Apr 15;22(8):1885-96. doi: 10.1158/1078-0432.CCR-15-1509. Review.

3.
4.

Personalized approaches to active immunotherapy in cancer.

Ophir E, Bobisse S, Coukos G, Harari A, Kandalaft LE.

Biochim Biophys Acta. 2016 Jan;1865(1):72-82. doi: 10.1016/j.bbcan.2015.07.004. Epub 2015 Aug 1. Review.

PMID:
26241169
5.

Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.

Dutton-Regester K, Hayward NK.

Adv Pharmacol. 2012;65:399-435. doi: 10.1016/B978-0-12-397927-8.00013-0. Review.

PMID:
22959033
6.

Biomarkers for personalized oncology: recent advances and future challenges.

Kalia M.

Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. doi: 10.1016/j.metabol.2014.10.027. Epub 2014 Oct 30. Review.

PMID:
25468140
7.

Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity.

Rivoltini L, Loftus DJ, Squarcina P, Castelli C, Rini F, Arienti F, Belli F, Marincola FM, Geisler C, Borsatti A, Appella E, Parmiani G.

Crit Rev Immunol. 1998;18(1-2):55-63. Review.

PMID:
9419448
8.

Mutanome directed cancer immunotherapy.

Vormehr M, Diken M, Boegel S, Kreiter S, Türeci Ö, Sahin U.

Curr Opin Immunol. 2016 Apr;39:14-22. doi: 10.1016/j.coi.2015.12.001. Epub 2015 Dec 21. Review.

PMID:
26716729
9.

Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format.

Diken M, Kreiter S, Kloke B, Sahin U.

Prog Tumor Res. 2015;42:44-54. doi: 10.1159/000437184. Epub 2015 Sep 4. Review.

PMID:
26383626
10.

Evolving role of tumor antigens for future melanoma therapies.

Andrews MC, Woods K, Cebon J, Behren A.

Future Oncol. 2014 Jun;10(8):1457-68. doi: 10.2217/fon.14.84. Review.

PMID:
25052755
11.

Multipeptide vaccination in cancer patients.

Pilla L, Rivoltini L, Patuzzo R, Marrari A, Valdagni R, Parmiani G.

Expert Opin Biol Ther. 2009 Aug;9(8):1043-55. doi: 10.1517/14712590903085109. Review.

PMID:
19591629
12.

The immunogenic properties of human melanomas and melanoma-associated antigens recognized by cytotoxic T lymphocytes.

Zeuthen J, Dzhandzhugazyan K, Hansen MR, Kirkin AF.

Bratisl Lek Listy. 1998 Aug-Sep;99(8-9):426-34. Review.

PMID:
9810766
13.

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.

Shouval D, Roggendorf H, Roggendorf M.

Med Microbiol Immunol. 2015 Feb;204(1):57-68. doi: 10.1007/s00430-014-0374-x. Epub 2015 Jan 4. Review.

14.

Melanoma vaccines.

Brinckerhoff LH, Thompson LW, Slingluff CL Jr.

Curr Opin Oncol. 2000 Mar;12(2):163-73. Review. Erratum in: Curr Opin Oncol 2001 Sep;13(5):413.

PMID:
10750729
15.

Immunogenic HER-2/neu peptides as tumor vaccines.

Baxevanis CN, Sotiriadou NN, Gritzapis AD, Sotiropoulou PA, Perez SA, Cacoullos NT, Papamichail M.

Cancer Immunol Immunother. 2006 Jan;55(1):85-95. Epub 2005 Oct 27. Review.

PMID:
15948002
16.

DNA minigene vaccination for adjuvant neuroblastoma therapy.

Lode HN, Huebener N, Zeng Y, Fest S, Weixler S, Gaedicke G.

Ann N Y Acad Sci. 2004 Dec;1028:113-21. Review.

PMID:
15650237
17.

[Vaccine strategies against melanoma].

Ghiringhelli F, Zitvogel L.

Med Sci (Paris). 2006 Feb;22(2):183-7. Review. French.

18.

Developing an effective breast cancer vaccine: challenges to achieving sterile immunity versus resetting equilibrium.

Curigliano G, Criscitiello C, Esposito A, Fumagalli L, Gelao L, Locatelli M, Minchella I, Goldhirsch A.

Breast. 2013 Aug;22 Suppl 2:S96-9. doi: 10.1016/j.breast.2013.07.018. Review.

PMID:
24074802
19.

Melanoma cancer vaccines and anti-tumor T cell responses.

Vujanovic L, Butterfield LH.

J Cell Biochem. 2007 Oct 1;102(2):301-10. Review.

PMID:
17647270
20.

Therapeutic vaccination with tumor cells that engage CD137.

Hellstrom KE, Hellstrom I.

J Mol Med (Berl). 2003 Feb;81(2):71-86. Epub 2003 Feb 8. Review.

PMID:
12601523

Supplemental Content

Support Center